DJIA 18,034.93 0.00 0.00%
NASDAQ 4,994.60 0.00 0.00%
S&P 500 2,100.40 0.00 0.00%
market minute promo

Array BioPharma (NASDAQ: ARRY)

7.43 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARRY $7.43 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $7.43
Daily Range $0.00 - $0.00
52-Week Range $2.98 - $8.59
Market Cap $1.0B
P/E Ratio -10.77
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 1,770,018
Current FY EPS -$0.08




Drug Makers

Array BioPharma (ARRY) Description

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Website:

News & Commentary

Why Array BioPharma Inc. Shares Skyrocketed 51% in January

Array BioPharma racks up enormous gains to start the new year after announcing a steal of a deal. Find out whether or not there's more upside potential after its huge run.

Array BioPharma CEO Sees Big Opportunities in the Future

4 Biotechs Expected to See Huge Buying on PowerShares Rebalance

Novartis Gets FTC Nod To Buyout Glaxo Smithkline's Cancer Drugs

Can These Three BioTech Companies Make It Big?

Investing In Precision Oncology: Targeting NTRK Genomic Alterations

Tuesday's ETF Movers: XBI, GDXJ

Oncolytics Seeks Orphan Drug Status for Reolysin in the U.S. - Analyst Blog

Oncolytics Seeks Orphan Drug Status for Reolysin in the U.S. - Analyst Blog

Strong On High Volume: Array BioPharma (ARRY)

Array BioPharma's (ARRY) CEO Ron Squarer on Q2 2015 Results - Earnings Call Transcript

See More ARRY News...

ARRY's Top Competitors

ARRY $7.43 (0.00%)
Current stock: ARRY
AMGN $165.97 (0.00%)
Current stock: AMGN
GILD $100.66 (0.00%)
Current stock: GILD
BIIB $422.92 (0.00%)
Current stock: BIIB